Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 239

1.

The clinical importance of the metabolite equol-a clue to the effectiveness of soy and its isoflavones.

Setchell KD, Brown NM, Lydeking-Olsen E.

J Nutr. 2002 Dec;132(12):3577-84. Review.

2.

Metabolism of dietary soy isoflavones to equol by human intestinal microflora--implications for health.

Yuan JP, Wang JH, Liu X.

Mol Nutr Food Res. 2007 Jul;51(7):765-81. Review.

PMID:
17579894
4.
5.

Equol is more active than soy isoflavone itself to compete for binding to thromboxane A(2) receptor in human platelets.

Muñoz Y, Garrido A, Valladares L.

Thromb Res. 2009 Mar;123(5):740-4. doi: 10.1016/j.thromres.2008.07.011. Epub 2008 Sep 10.

PMID:
18786699
6.

Equol, a natural estrogenic metabolite from soy isoflavones: convenient preparation and resolution of R- and S-equols and their differing binding and biological activity through estrogen receptors alpha and beta.

Muthyala RS, Ju YH, Sheng S, Williams LD, Doerge DR, Katzenellenbogen BS, Helferich WG, Katzenellenbogen JA.

Bioorg Med Chem. 2004 Mar 15;12(6):1559-67.

PMID:
15018930
7.

Urinary equol excretion with a soy challenge: influence of habitual diet.

Lampe JW, Karr SC, Hutchins AM, Slavin JL.

Proc Soc Exp Biol Med. 1998 Mar;217(3):335-9.

PMID:
9492344
8.

S-equol, a potent ligand for estrogen receptor beta, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora.

Setchell KD, Clerici C, Lephart ED, Cole SJ, Heenan C, Castellani D, Wolfe BE, Nechemias-Zimmer L, Brown NM, Lund TD, Handa RJ, Heubi JE.

Am J Clin Nutr. 2005 May;81(5):1072-9.

9.

Bioavailability and urinary excretion of isoflavones in humans: effects of soy-based supplements formulation and equol production.

Vergne S, Titier K, Bernard V, Asselineau J, Durand M, Lamothe V, Potier M, Perez P, Demotes-Mainard J, Chantre P, Moore N, Bennetau-Pelissero C, Sauvant P.

J Pharm Biomed Anal. 2007 Mar 12;43(4):1488-94. Epub 2006 Nov 15.

PMID:
17110073
10.

Isoflavones, equol and cardiovascular disease: pharmacological and therapeutic insights.

Jackman KA, Woodman OL, Sobey CG.

Curr Med Chem. 2007;14(26):2824-30. Review.

PMID:
18045128
11.
12.

Gut bacterial metabolism of the soy isoflavone daidzein: exploring the relevance to human health.

Atkinson C, Frankenfeld CL, Lampe JW.

Exp Biol Med (Maywood). 2005 Mar;230(3):155-70. Review.

PMID:
15734719
13.

Soybean isoflavones in bone health.

Ishimi Y.

Forum Nutr. 2009;61:104-16. doi: 10.1159/000212743. Epub 2009 Apr 7. Review.

PMID:
19367115
14.

Wheat bran and soy protein feeding do not alter urinary excretion of the isoflavan equol in premenopausal women.

Lampe JW, Skor HE, Li S, Wähälä K, Howald WN, Chen C.

J Nutr. 2001 Mar;131(3):740-4.

15.

Soy isoflavonoid equol modulates the growth of benign and malignant prostatic epithelial cells in vitro.

Hedlund TE, Johannes WU, Miller GJ.

Prostate. 2003 Jan 1;54(1):68-78.

PMID:
12481257
16.

Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements.

Setchell KD, Brown NM, Desai P, Zimmer-Nechemias L, Wolfe BE, Brashear WT, Kirschner AS, Cassidy A, Heubi JE.

J Nutr. 2001 Apr;131(4 Suppl):1362S-75S.

17.

Estrogenicity of the isoflavone metabolite equol on reproductive and non-reproductive organs in mice.

Selvaraj V, Zakroczymski MA, Naaz A, Mukai M, Ju YH, Doerge DR, Katzenellenbogen JA, Helferich WG, Cooke PS.

Biol Reprod. 2004 Sep;71(3):966-72. Epub 2004 May 19.

18.

Soy processing affects metabolism and disposition of dietary isoflavones in ovariectomized BALB/c mice.

Allred CD, Twaddle NC, Allred KF, Goeppinger TS, Churchwell MI, Ju YH, Helferich WG, Doerge DR.

J Agric Food Chem. 2005 Nov 2;53(22):8542-50.

PMID:
16248551
19.

Modulation of soy isoflavones bioavailability and subsequent effects on bone health in ovariectomized rats: the case for equol.

Mathey J, Mardon J, Fokialakis N, Puel C, Kati-Coulibaly S, Mitakou S, Bennetau-Pelissero C, Lamothe V, Davicco MJ, Lebecque P, Horcajada MN, Coxam V.

Osteoporos Int. 2007 May;18(5):671-9. Epub 2007 Feb 28.

PMID:
17333448
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk